Raising the prices of life-saving drugs is a sadly common if morally reprehensible practice in corporate America, where the profits of pharmaceutical corporations are more important than the lives of their customers.
Nothing embodies the callous cruelty of the price-gouger than Robert Coury, the chairman of the Mylan company which owns the rights to the ubiquitous Epi-Pen.
He has a simple message for Americans who don’t like his decision to drastically raise the price of the Epi-Pen and extort millions from the American people in exchange for the survival of their children:
Go f*ck yourself.
The New York Times reports that when executives began worrying about the consequences and the ethics of raising the price so high in 2014, Coury literally used those words to describe what his critics could go do.
Mr. Coury replied that he was untroubled. He raised both his middle fingers and explained, using colorful language, that anyone criticizing Mylan, including its employees, ought to go copulate with themselves. Critics in Congress and on Wall Street, he said, should do the same. And regulators at the Food and Drug Administration? They, too, deserved a round of anatomically challenging self-fulfillment.
Epi-Pens contain an injection containing epinephrine, which helps alleviate the symptoms of many allergic reactions. 15 million Americans – 1 in 13 children – have food allergies capable of sending them into anaphylactic shock, making Epi-Pens a life-saving device that needs to be widely available for all to use.
But the maker of the Epi-Pen, Mylan, has been jacking up the price sky-high, raising it from $164 to $608 since 2011 and making millions of dollars off of a product that millions of Americans rely on.
keyboard shortcuts: V vote up article J next comment K previous comment